Lv11
64 积分 2024-12-01 加入
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
51分钟前
已完结
First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study
14天前
已完结
Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
17天前
已完结
Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres
1个月前
已完结
Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review
2个月前
已完结
90 Y Radiation Segmentectomy for Curative Intent in HCC: From Art to Science
2个月前
已完结
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score
3个月前
已完结
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
3个月前
已完结
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
3个月前
已完结
Fusobacterium nucleatum alleviates alcohol-associated liver disease through mannose-mediated elevation of Fbp1 and modulation of gut microbiota
4个月前
已完结
皖公网安备34019202002308
